152 related articles for article (PubMed ID: 21394520)
1. Etomidate use in severe sepsis and septic shock patients does not contribute to mortality.
Ehrman R; Wira C; Lomax A; Hayward A; Marcelin J; Ellis T; Przyklenk K; Volturo G; Mullen M
Intern Emerg Med; 2011 Jun; 6(3):253-7. PubMed ID: 21394520
[TBL] [Abstract][Full Text] [Related]
2. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database.
McPhee LC; Badawi O; Fraser GL; Lerwick PA; Riker RR; Zuckerman IH; Franey C; Seder DB
Crit Care Med; 2013 Mar; 41(3):774-83. PubMed ID: 23318491
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of etomidate in severe sepsis and septic shock.
Dmello D; Taylor S; O'Brien J; Matuschak GM
Chest; 2010 Dec; 138(6):1327-32. PubMed ID: 20651024
[TBL] [Abstract][Full Text] [Related]
4. Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis.
Jung B; Clavieras N; Nougaret S; Molinari N; Roquilly A; Cisse M; Carr J; Chanques G; Asehnoune K; Jaber S
Crit Care; 2012 Nov; 16(6):R224. PubMed ID: 23171852
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for mortality in septic patients who received etomidate.
Rech MA; Bennett S; Chaney W; Sterk E
Am J Emerg Med; 2015 Oct; 33(10):1340-3. PubMed ID: 26321168
[TBL] [Abstract][Full Text] [Related]
6. Relative adrenal insufficiency in etomidate-naïve patients with septic shock.
Jones D; Hayes M; Webb S; French C; Bellomo R
Anaesth Intensive Care; 2006 Oct; 34(5):599-605. PubMed ID: 17061634
[TBL] [Abstract][Full Text] [Related]
7. Effects of etomidate on vasopressor use in patients with sepsis or severe sepsis: a propensity-matched analysis.
Alday NJ; Jones GM; Kimmons LA; Phillips GS; McCallister JW; Doepker BA
J Crit Care; 2014 Aug; 29(4):517-22. PubMed ID: 24629575
[TBL] [Abstract][Full Text] [Related]
8. A prospective observational study of the effect of etomidate on septic patient mortality and length of stay.
Tekwani KL; Watts HF; Rzechula KH; Sweis RT; Kulstad EB
Acad Emerg Med; 2009 Jan; 16(1):11-4. PubMed ID: 19055676
[TBL] [Abstract][Full Text] [Related]
9. Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock.
Kim TY; Rhee JE; Kim KS; Cha WC; Suh GJ; Jung SK
J Korean Med Sci; 2008 Dec; 23(6):988-91. PubMed ID: 19119441
[TBL] [Abstract][Full Text] [Related]
10. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate.
Mohammad Z; Afessa B; Finkielman JD
Crit Care; 2006; 10(4):R105. PubMed ID: 16859529
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
[TBL] [Abstract][Full Text] [Related]
12. Mortality predictors in renal transplant recipients with severe sepsis and septic shock.
de Carvalho MA; Freitas FG; Silva Junior HT; Bafi AT; Machado FR; Pestana JO
PLoS One; 2014; 9(11):e111610. PubMed ID: 25369197
[TBL] [Abstract][Full Text] [Related]
13. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
Cheung WK; Chau LS; Mak II; Wong MY; Wong SL; Tiwari AF
Intensive Crit Care Nurs; 2015 Dec; 31(6):359-65. PubMed ID: 26292920
[TBL] [Abstract][Full Text] [Related]
14. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*.
Chan CM; Mitchell AL; Shorr AF
Crit Care Med; 2012 Nov; 40(11):2945-53. PubMed ID: 22971586
[TBL] [Abstract][Full Text] [Related]
15. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality.
den Brinker M; Joosten KF; Liem O; de Jong FH; Hop WC; Hazelzet JA; van Dijk M; Hokken-Koelega AC
J Clin Endocrinol Metab; 2005 Sep; 90(9):5110-7. PubMed ID: 15985474
[TBL] [Abstract][Full Text] [Related]
16. Etomidate for intubation of patients who have sepsis or septic shock--where do we go from here?
Griesdale DE
Crit Care; 2012 Dec; 16(6):189. PubMed ID: 23273139
[TBL] [Abstract][Full Text] [Related]
17. Site of infection and mortality in patients with severe sepsis or septic shock. A cohort study of patients admitted to a Danish general intensive care unit.
Klastrup V; Hvass AM; Mackenhauer J; Fuursted K; Schønheyder HC; Kirkegaard H;
Infect Dis (Lond); 2016 Oct; 48(10):726-31. PubMed ID: 27389656
[TBL] [Abstract][Full Text] [Related]
18. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
[TBL] [Abstract][Full Text] [Related]
19. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock.
Cuthbertson BH; Sprung CL; Annane D; Chevret S; Garfield M; Goodman S; Laterre PF; Vincent JL; Freivogel K; Reinhart K; Singer M; Payen D; Weiss YG
Intensive Care Med; 2009 Nov; 35(11):1868-76. PubMed ID: 19652948
[TBL] [Abstract][Full Text] [Related]
20. A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock.
Awad WB; Nazer L; Elfarr S; Abdullah M; Hawari F
BMC Cancer; 2021 Jun; 21(1):709. PubMed ID: 34130642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]